Method of Participation/Claiming CE Credit
There are no fees to participate in the activities of this curriculum. Learners must review the CME handout for the activity you wish to participate in including the learning objectives and disclosure statements, as well as the content of the activity. To receive CME/CNE/CPE credit for your participation, please complete the post-activity assessment via the link you are provided at the conclusion of the activity. Your certificate will be emailed to you.
For pharmacists, a statement of credit will be issued through CPE Monitor in 6-8 weeks. Only learners who provided valid NABP e-Profile ID numbers and month and day of birth (MMDD) will be submitted to CPE Monitor for official record of credit.
______________________________
Curriculum Planner and Faculty Disclosures
According to the disclosure policy of the Academy, all faculty, planning committee members, editors, managers and other individuals who are in a position to control content are required to disclose any relationships with any ineligible company(ies). The existence of these relationships is not viewed as implying bias or decreasing the value of the activity. Clinical content has been reviewed for fair balance and scientific objectivity, and all of the relevant financial relationships listed for these individuals have been mitigated.
Faculty disclosures can be found on the CME handout for each webinar.
Planner Disclosures |
|
|---|---|
Roger Bedimo, MD |
Advisory Board/Consultant: ViiV Healthcare, Merck, Theratechnologies* |
Tomasz Z. Jodlowski, PharmD |
No financial relationships with ineligible companies |
Natalie Kirkwood RN, BSN, JD |
No financial relationships with ineligible companies |
Paul J. Miniter, MS |
No financial relationships with ineligible companies |
*Relationship has ended |
Off-Label Disclosure
This curriculum will include discussion of off-label uses of approved agents as well as information about investigational agents.
The opinions expressed in this accredited continuing education curriculum are those of the faculty, and do not represent those of the Academy or VA North Texas Health Care System (VANTHCS) Infectious Diseases Section. This educational curriculum is intended as a supplement to existing knowledge, published information, and practice guidelines. Learners should appraise the information presented critically, and draw conclusions only after careful consideration of all available scientific information.
Curriculum Support
Support for this accredited continuing education curriculum has been made possible through educational grants from Gilead Sciences and ViiV Healthcare